Longitudinal Frailty Status in Rheumatoid Arthritis and Its Association With Disease Activity and Glucocorticoid Use
International Journal of Rheumatic Diseases · 2026-07 · 29 (7)
DOI: 10.1111/1756-185x.70758 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 29.06.2026. Verfasst von Yoshifumi Ohashi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Aichi Medical University, Graduate School of Medicine, Nagakute, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Glucocorticoids, Frailty. Die Arbeit nennt 34 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objective
To examine factors associated with a higher long‐term frailty status in patients with rheumatoid arthritis (RA).
Methods
We analyzed 313 patients who had complete annual Japanese version of the Cardiovascular Health Study (J‐CHS) assessments from 2020 to 2025. Frailty status was evaluated using the mean J‐CHS score across the study period, and patients were classified into two groups: mean J‐CHS ≤ 2 ( n = 236) and mean J‐CHS > 2 ( n = 77). Factors associated with mean J‐CHS > 2 were examined using logistic regression analysis.
Results
Compared to patients with mean J‐CHS ≤ 2, those with mean J‐CHS > 2 were older (63.9 vs. 68.2 years) and had a longer disease duration (9.8 vs. 15.1 years), higher disease activity (mean DAS28‐ESR: 2.44 vs. 3.17), higher rate of glucocorticoid use (23.3% vs. 36.4%), and worse physical function (mean HAQ‐DI: 0.21 vs. 0.77). Logistic regression analysis identified longer disease duration (OR 1.06), higher DAS28‐ESR (OR 2.38), and glucocorticoid use (OR 2.90) as independent factors associated with mean J‐CHS > 2. In longitudinal analyses, patients with higher frailty status consistently exhibited higher glucocorticoid use over time. Among patients who achieved baseline remission, disease activity remained comparable between groups, whereas glucocorticoid use remained consistently higher in patients with mean J‐CHS > 2.
Conclusions
Long‐term frailty status in RA was associated with disease duration and treatment patterns, particularly continued glucocorticoid exposure. Even among patients in remission, those with mean J‐CHS > 2 showed persistently higher glucocorticoid use despite comparable disease activity, without corresponding DMARD intensification, which may reflect differences in treatment patterns in this subgroup.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Aichi Medical University, Graduate School of Medicine, Nagakute, Japan.
- Department of Orthopedic Surgery, Yokkaichi Municipal Hospital, Yokkaichi, Mie, Japan.
- Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Orthopedic Surgery, Japan Community Health Care Organization, Kani Tono Hospital, Gifu, Japan.
- Department of Orthopedic Surgery, Japan Red Cross, Aichi Medical Center, Nagoya Daiichi Hospital, Nagoya, Japan.
ORCID-Profile: Mochihito Suzuki, Yasumori Sobue, Nobunori Takahashi
Zitieren
APA
Ohashi, Y., Suzuki, M., Sobue, Y., Terabe, K., Asai, S., Imagama, S., & Takahashi, N. (2026). Longitudinal Frailty Status in Rheumatoid Arthritis and Its Association With Disease Activity and Glucocorticoid Use. International Journal of Rheumatic Diseases, 29(7). https://doi.org/10.1111/1756-185x.70758
Vancouver
Ohashi Y, Suzuki M, Sobue Y, Terabe K, Asai S, Imagama S, et al. Longitudinal Frailty Status in Rheumatoid Arthritis and Its Association With Disease Activity and Glucocorticoid Use. International Journal of Rheumatic Diseases. 2026;29(7). doi:10.1111/1756-185x.70758
BibTeX
@article{Ohashi2026,
author = {Ohashi, Yoshifumi and Suzuki, Mochihito and Sobue, Yasumori and Terabe, Kenya and Asai, Shuji and Imagama, Shiro and Takahashi, Nobunori},
title = {Longitudinal Frailty Status in Rheumatoid Arthritis and Its Association With Disease Activity and Glucocorticoid Use},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
volume = {29},
number = {7},
doi = {10.1111/1756-185x.70758}
}
EUVIMED